• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Polymer Factory Granted Dendritic Nanogel (DNG) Patent in Multiple European Countries

POLYMERRegulatory press release29.08.2025, 08.00
Download the release

Polymer Factory Sweden AB (publ) today announced that its patent application for the Company's dendritic nanogel (DNG) platform has been granted in several European countries.

The DNG platform is an innovative nanocarrier system based on dendritic materials, designed to encapsulate, transport, and control the release of various cargos, including pharmaceuticals, peptides, and antibiotics. DNG offers a novel alternative to established drug delivery systems such as polymeric micelles and liposomes.

"A strong patent protection is valuable both for Polymer Factory and for potential future partners. Our main commercial focus is on Europe and the USA, which makes this decision an important step forward in our journey to commercialize the DNG platform," said Mats Wallnér, CEO of Polymer Factory.

The patent was filed on August 13, 2019, and will be valid for 20 years from the date of grant, ensuring market exclusivity during this period. This follows the Company's previously granted DNG patents in the United States and China in 2024.